Back to Journals » Therapeutics and Clinical Risk Management » Volume 14

Original Research

Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson's disease: systematic review, meta-analysis, and economic evaluation

       
Total article views   HTML views PDF downloads Totals
18,184 Dovepress* 15,403+ 1,660 17,063
PubMed Central* 2,781 769 3,550
Totals 18,184 2,429 20,613
*Since 16 April 2018

View citations on PubMed and Google Scholar